Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2022 Earnings Call Transcript March 6, 2023
Operator: Thank you for standing by, and welcome to Coherus Biosciences Fourth Quarter and Fiscal Year 2022 Earnings Conference Call. I would now like to hand the call over to SVP, Investor Relations, Marek Ciszewski. Please go ahead.
Marek Ciszewski: Thank you, Latif, and good afternoon, everyone, and thank you for joining us. We issued a press release earlier today announcing our financial results for...
